Reviews in cardiovascular medicine最新文献

筛选
英文 中文
Mechanism of Coronary Microcirculation Obstruction after Acute Myocardial Infarction and Cardioprotective Strategies. 急性心肌梗死后冠状动脉微循环阻塞的机制与心脏保护策略
IF 1.9 4区 医学
Reviews in cardiovascular medicine Pub Date : 2024-10-12 eCollection Date: 2024-10-01 DOI: 10.31083/j.rcm2510367
Yuyu Li, Jiaqi Yu, Yuan Wang
{"title":"Mechanism of Coronary Microcirculation Obstruction after Acute Myocardial Infarction and Cardioprotective Strategies.","authors":"Yuyu Li, Jiaqi Yu, Yuan Wang","doi":"10.31083/j.rcm2510367","DOIUrl":"10.31083/j.rcm2510367","url":null,"abstract":"<p><p>ST-segment elevation myocardial infarction patients are best treated with emergency percutaneous coronary intervention (PCI), while coronary microvascular dysfunction and obstruction (CMVO) are indicated by the absence or slowing of antegrade epicardial flow on angiography, resulting in suboptimal myocardial perfusion despite the lack of mechanical vascular obstruction. CMVO occurs in up to half of patients who undergo PCI for the first time and is associated with poor outcomes. This review summarizes the complex mechanisms leading to CMVO and elaborates on the changes observed at the organism, tissue, organ, cellular, and molecular levels. It also describes the current diagnostic methods and comprehensive treatment methods for CMVO.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522835/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular Disease in Chronic Kidney Disease: Implications of Cardiorespiratory Fitness, Race, and Sex. 慢性肾脏病中的心血管疾病:心肺功能、种族和性别的影响。
IF 1.9 4区 医学
Reviews in cardiovascular medicine Pub Date : 2024-10-11 eCollection Date: 2024-10-01 DOI: 10.31083/j.rcm2510365
Jared M Gollie, Gauranga Mahalwar
{"title":"Cardiovascular Disease in Chronic Kidney Disease: Implications of Cardiorespiratory Fitness, Race, and Sex.","authors":"Jared M Gollie, Gauranga Mahalwar","doi":"10.31083/j.rcm2510365","DOIUrl":"10.31083/j.rcm2510365","url":null,"abstract":"<p><p>Cardiovascular disease (CVD) poses a major health burden in adults with chronic kidney disease (CKD). While cardiorespiratory fitness, race, and sex are known to influence the relationship between CVD and mortality in the absence of kidney disease, their roles in patients with CKD remain less clear. Therefore, this narrative review aims to synthesize the existing data on CVD in CKD patients with a specific emphasis on cardiorespiratory fitness, race, and sex. It highlights that both traditional and non-traditional risk factors contribute to CVD development in this population. Additionally, biological, social, and cultural determinants of health contribute to racial disparities and sex differences in CVD outcomes in patients with CKD. Although cardiorespiratory fitness levels also differ by race and sex, their influence on CVD and cardiovascular mortality is consistent across these groups. Furthermore, exercise has been shown to improve cardiorespiratory fitness in CKD patients regardless of race or sex. However, the specific effects of exercise on CVD risk factors in CKD patients, particularly across different races and sexes remains poorly understood and represent a critical area for future research.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulated Cell Death Pathways in Pathological Cardiac Hypertrophy. 病理性心肌肥大中的细胞死亡调控途径
IF 1.9 4区 医学
Reviews in cardiovascular medicine Pub Date : 2024-10-11 eCollection Date: 2024-10-01 DOI: 10.31083/j.rcm2510366
Shengnan Wu, Ding Ding, Deguo Wang
{"title":"Regulated Cell Death Pathways in Pathological Cardiac Hypertrophy.","authors":"Shengnan Wu, Ding Ding, Deguo Wang","doi":"10.31083/j.rcm2510366","DOIUrl":"10.31083/j.rcm2510366","url":null,"abstract":"<p><p>Cardiac hypertrophy is characterized by an increased volume of individual cardiomyocytes rather than an increase in their number. Myocardial hypertrophy due to pathological stimuli encountered by the heart, which reduces pressure on the ventricular walls to maintain cardiac function, is known as pathological hypertrophy. This eventually progresses to heart failure. Certain varieties of regulated cell death (RCD) pathways, including apoptosis, pyroptosis, ferroptosis, necroptosis, and autophagy, are crucial in the development of pathological cardiac hypertrophy. This review summarizes the molecular mechanisms and signaling pathways underlying these RCD pathways, focusing on their mechanism of action findings for pathological cardiac hypertrophy. It intends to provide new ideas for developing therapeutic approaches targeted at the cellular level to prevent or reverse pathological cardiac hypertrophy.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progress of Conductivity and Conduction Velocity Measured in Human and Animal Hearts. 在人类和动物心脏中测量的传导性和传导速度的进展。
IF 1.9 4区 医学
Reviews in cardiovascular medicine Pub Date : 2024-10-11 eCollection Date: 2024-10-01 DOI: 10.31083/j.rcm2510364
Zhenyin Fu, Ruiqing Dong, Huanyong Zheng, Zefeng Wang, Boyang Cao, Jinghui Bai, Mingxia Ma, Zhanchun Song, Fuzhi Pan, Ling Xia, Yongquan Wu, Shijie Zhou, Dongdong Deng
{"title":"Progress of Conductivity and Conduction Velocity Measured in Human and Animal Hearts.","authors":"Zhenyin Fu, Ruiqing Dong, Huanyong Zheng, Zefeng Wang, Boyang Cao, Jinghui Bai, Mingxia Ma, Zhanchun Song, Fuzhi Pan, Ling Xia, Yongquan Wu, Shijie Zhou, Dongdong Deng","doi":"10.31083/j.rcm2510364","DOIUrl":"10.31083/j.rcm2510364","url":null,"abstract":"<p><p>Cardiac conduction velocity (CV) is a critical electrophysiological characteristic of the myocardium, representing the speed at which electrical pulses propagate through cardiac tissue. It can be delineated into longitudinal, transverse, and normal components in the myocardium. The CV and its anisotropy ratio are crucial to both normal electrical conduction and myocardial contraction, as well as pathological conditions where it increases the risk of conduction block and reentry. This comprehensive review synthesizes longitudinal and transverse CV values from clinical and experimental studies of human infarct hearts, including findings from the isthmus and outer loop, alongside data derived from animal models. Additionally, we explore the anisotropic ratio of conductivities assessed through both animal and computational models. The review culminates with a synthesis of scientific evidence that guides the selection of CV and its corresponding conductivity in cardiac modeling, particularly emphasizing its application in patient-specific cardiac arrhythmia modeling.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association between Fatty Liver Index and Lower Limb Arterial Calcification in Patients with Type 2 Diabetes Mellitus. 2 型糖尿病患者脂肪肝指数与下肢动脉钙化之间的关系
IF 1.9 4区 医学
Reviews in cardiovascular medicine Pub Date : 2024-10-10 eCollection Date: 2024-10-01 DOI: 10.31083/j.rcm2510362
Peibiao Mai, Qilong Li, Sijin Li, Chunhong Wang, Shuwan Xu, Kun Zhang, Niansang Luo
{"title":"The Association between Fatty Liver Index and Lower Limb Arterial Calcification in Patients with Type 2 Diabetes Mellitus.","authors":"Peibiao Mai, Qilong Li, Sijin Li, Chunhong Wang, Shuwan Xu, Kun Zhang, Niansang Luo","doi":"10.31083/j.rcm2510362","DOIUrl":"10.31083/j.rcm2510362","url":null,"abstract":"<p><strong>Background: </strong>Peripheral arterial calcification is a prevalent condition in patients with type 2 diabetes mellitus (T2DM), resulting in lower-limb amputation and reduced life quality. Non-alcoholic fatty liver disease (NAFLD), which can be simply evaluated using the fatty liver index (FLI), is closely associated with T2DM development. In this study, we aimed to explore the relationship between FLI and lower limb arterial calcification (LLAC) in T2DM patients and to reveal the value of T2DM patients with NAFLD in predicting the occurrence of LLAC.</p><p><strong>Methods: </strong>A total of 77 T2DM patients with LLAC who underwent comprehensive physical and health examinations, serological examinations, as well as lower limb computed tomography imaging at Sun Yat-sen Memorial Hospital of Sun Yat-sen University between January 2018 and January 2019 were enrolled in this study. The FLI was calculated using body mass index, waist circumference, triglycerides, and γ-glutamyl transferase. Additionally, LLAC was evaluated using computed tomography with the Agatston scoring algorithm. The patients were divided into three groups based on their FLI values: Non-liver disease group (FLI <30, n = 29), borderline-liver disease group (30 ≤ FLI < 60, n = 32), and NAFLD group (FLI ≥60, n = 16). Univariate and multivariate binary logistic regression analyses were employed to investigate the association between FLI and LLAC in T2DM patients. Furthermore, differences in LLAC among groups were analyzed using post-hoc multiple comparisons and ordinal logistic regression model analysis.</p><p><strong>Results: </strong>Univariate and multivariate analyses showed that age and FLI influenced LLAC severity in T2DM patients. Moreover, T2DM patients in the NAFLD group had significantly lower LLAC scores than those in the Non-liver disease group. The correlation analysis showed that FLI was negatively associated with LLAC scores (R = -0.31, <i>p</i> = 0.006), while age was positively associated (R = 0.361, <i>p</i> = 0.001).</p><p><strong>Conclusions: </strong>Our study revealed an inverse relationship between FLI and the degree of LLAC. This indicates that, based on evidence in the current research, NAFLD may not be reliable as a predictor of LLAC in T2DM patients.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522770/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Retrospective Analysis of Late Open Conversions Following Failed Endovascular Aneurysm Repair. 血管内动脉瘤修补失败后晚期开放手术转归的回顾性分析。
IF 1.9 4区 医学
Reviews in cardiovascular medicine Pub Date : 2024-10-10 eCollection Date: 2024-10-01 DOI: 10.31083/j.rcm2510363
Bahadır Aytekin, Bekir Boğaçhan Akkaya, Hayrettin Levent Mavioğlu, Hakkı Zafer İşcan
{"title":"A Retrospective Analysis of Late Open Conversions Following Failed Endovascular Aneurysm Repair.","authors":"Bahadır Aytekin, Bekir Boğaçhan Akkaya, Hayrettin Levent Mavioğlu, Hakkı Zafer İşcan","doi":"10.31083/j.rcm2510363","DOIUrl":"10.31083/j.rcm2510363","url":null,"abstract":"<p><strong>Background: </strong>The incidence of late open surgical conversions (OSCs) has recently increased. Vascular surgeons face additional technical challenges in late conversion surgery of failed endovascular aneurysm repair (EVAR) due to the presence of a previously deployed endograft. Based on our institutional experience, this study aimed to delineate methods to improve late open conversion outcomes, proposing solutions for technical challenges.</p><p><strong>Methods: </strong>All preoperative OSC data on failed EVARs operated in our Cardiovascular Surgery Clinic between January 2017 and January 2024 were evaluated retrospectively. Study endpoints included early (30-day or in-hospital) and late follow-up outcomes. Early outcomes included perioperative mortality and morbidities, intensive care unit (ICU) period, and length of hospital stay (LOS). The main outcome of interest during follow-up was overall survival.</p><p><strong>Results: </strong>Sixteen patients in our hospital, comprising eight elective and eight emergency procedures, underwent OSCs following EVAR. The difference between the 30-day mortality rates for the elective and urgent late conversions was significant (<i>p</i> < 0.001). Of these patients, 15 were male, with a mean age of 70.8 years (range: 62-80). Preoperative cardiac shock status and low hematocrit level (<20%) were independent mortality factors (<i>p</i> < 0.001). The ICU period was 8.7 ± 5.3 days (2-20 days) on average, and LOS was 17.3 ± 8.4 (6-29 days) days on average. The mean time to open surgical conversion in this cohort was 44.4 ± 16.8 months. The 5-year overall survival rate was 43.75%.</p><p><strong>Conclusions: </strong>The incidence of open surgical conversion is notably growing. Emergent open surgical conversions exhibit poorer mortality outcomes compared to elective procedures. Further data are essential to evaluate the ramifications of expanding the use of EVAR beyond the instructions for use (IFU) guidelines. The procedures involving patients who challenge the IFU criteria should be conducted at experienced centers and require close monitoring. Open surgical repair (OSR) as the initial treatment opportunity could be an alternative strategy for improving outcomes in this patient cohort.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522759/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Postoperative Outcomes between Leadless and Conventional Transvenous Pacemakers Implantation: An Up-to-Date Meta-analysis. 无引线和传统经静脉起搏器植入术的术后效果比较:最新的 Meta 分析。
IF 1.9 4区 医学
Reviews in cardiovascular medicine Pub Date : 2024-10-09 eCollection Date: 2024-10-01 DOI: 10.31083/j.rcm2510359
Huimiao Dai, Hao Liu, Chuncheng Gao, Jing Han, Jun Meng, Pengyun Liu, Mingming Zhang, Dongdong Li, Wangang Guo
{"title":"Comparison of Postoperative Outcomes between Leadless and Conventional Transvenous Pacemakers Implantation: An Up-to-Date Meta-analysis.","authors":"Huimiao Dai, Hao Liu, Chuncheng Gao, Jing Han, Jun Meng, Pengyun Liu, Mingming Zhang, Dongdong Li, Wangang Guo","doi":"10.31083/j.rcm2510359","DOIUrl":"10.31083/j.rcm2510359","url":null,"abstract":"<p><strong>Background: </strong>Leadless cardiac pacemakers (LCPs) are emerging as viable alternatives to conventional transvenous pacemakers (TVPs). This study aimed to systematically compare the postoperative outcomes of LCPs and TVPs based on available published studies.</p><p><strong>Methods: </strong>We conducted a systematic review and meta-analysis of literature comparing outcomes from LCP and TVP implantations. Data analysis was performed using Stata/MP 17.0. The evaluated endpoints included pericardial effusion or perforation, puncture site events, infective endocarditis, lead or device dislodgement, pocket-related complications, tricuspid regurgitation or dysfunction, any infection, increased right ventricle (RV) pacing threshold, embolism, and thrombosis. Aggregated odds ratios (OR) and 95% confidence intervals (CI) were determined. Sensitivity analyses were conducted for heterogeneity if I<sup>2</sup> was >50% or <i>p</i> < 0.01, otherwise, the random-effects model was chosen. Publication bias was analyzed if the number studies exceeded ten.</p><p><strong>Results: </strong>The meta-analysis included 24 observational studies with 78,938 patients, comprising 24,191 with LCP implantation and 54,747 with TVP implantation. The results indicated a significantly lower incidence of lead or device dislodgment (OR = 3.32, 95% CI: 1.91-5.77, <i>p</i> < 0.01), infective endocarditis (OR = 3.62, 95% CI: 3.10-4.24, <i>p</i> < 0.01), and infection (OR = 3.93, 95% CI: 1.67-9.24, <i>p</i> < 0.01) in the LCP group compared to the TVP group. In contrast, incidences of puncture site complications (OR = 0.24, 95% CI: 0.19-0.32, <i>p <</i> 0.01) and pericardial effusion or perforation (OR = 0.33, 95% CI: 0.28-0.39, <i>p</i> < 0.01) were significantly higher in the LCP group.</p><p><strong>Conclusions: </strong>Compared with TVP, LCP implantation is associated with a lower risk of infective endocarditis, lead or device dislodgment, infections, and pocket-related complications. However, LCP implantation carries a higher risk of puncture site complications and pericardial effusion or perforation. These findings underscore the need for careful consideration of patient-specific factors when choosing between LCP and TVP implantation.</p><p><strong>The prospero registration: </strong>https://www.crd.york.ac.uk/prospero/ (CRD42023453145).</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ferroptosis and its Potential Determinant Role in Myocardial Susceptibility to Ischemia/Reperfusion Injury in Diabetes. 铁蛋白沉积及其在糖尿病心肌易缺血/再灌注损伤中的潜在决定性作用
IF 1.9 4区 医学
Reviews in cardiovascular medicine Pub Date : 2024-10-09 eCollection Date: 2024-10-01 DOI: 10.31083/j.rcm2510360
Dongcheng Zhou, Yuhui Yang, Ronghui Han, Jianfeng He, Danyong Liu, Weiyi Xia, Yin Cai, Bartłomiej Perek, Zhengyuan Xia
{"title":"Ferroptosis and its Potential Determinant Role in Myocardial Susceptibility to Ischemia/Reperfusion Injury in Diabetes.","authors":"Dongcheng Zhou, Yuhui Yang, Ronghui Han, Jianfeng He, Danyong Liu, Weiyi Xia, Yin Cai, Bartłomiej Perek, Zhengyuan Xia","doi":"10.31083/j.rcm2510360","DOIUrl":"10.31083/j.rcm2510360","url":null,"abstract":"<p><p>Myocardial ischemia/reperfusion injury (MIRI) is a major cause of cardiac death particularly in patients with diabetes. When the coronary artery is partially or completely blocked, restoration of blood perfusion can normally be achieved within a certain time due to the development of advanced techniques such as percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) surgery. However, cardiac tissue injury may aggravate progressively even after the ischemic myocardium is restored to normal perfusion. MIRI is often associated with various forms of cell death, including apoptosis, autophagy, programmed necrosis, pyroptosis, and ferroptosis, among others. Ferroptosis is known as iron-dependent cell death that is distinct from other programmed modes of cell death. Ferroptosis is under constitutive control by glutathione peroxidase 4 (GPX4), and the reduction of GPX4 may result in ferroptosis even if iron homeostasis is physiologically maintained. The essences of ferroptosis are substantial iron accumulation and lipid peroxidation that trigger cell death. Under impaired antioxidant system, cellular reactive oxygen species (ROS) accumulation leads to lipid peroxidation which consequently results in ferroptosis. Ferroptosis shares a few common features with several types of cell death and interplays with various forms of cell death such as autophagy and apoptosis in the development of cardiovascular diseases. More and more recent studies have demonstrated that ferroptosis plays an important role in MIRI. However, few studies have addressed the relative importance of ferroptosis in MIRI relative to other forms of cell deaths. In this review, we summarized the basic aspects and advances regarding the molecular pathogenesis of ferroptosis, evaluated its role in MIRI, and propose that the levels of ferroptosis may function as a major determinant of myocardial susceptibility to ischemia/reperfusion injury (IRI) in general and of the enhanced vulnerability to MIRI specifically in diabetes.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron Overload and Abdominal Aortic Aneurysm. 铁超载与腹主动脉瘤
IF 1.9 4区 医学
Reviews in cardiovascular medicine Pub Date : 2024-10-09 eCollection Date: 2024-10-01 DOI: 10.31083/j.rcm2510361
Yunyi Li, Quan Zhou, Kai Zhang, Xiao Meng
{"title":"Iron Overload and Abdominal Aortic Aneurysm.","authors":"Yunyi Li, Quan Zhou, Kai Zhang, Xiao Meng","doi":"10.31083/j.rcm2510361","DOIUrl":"10.31083/j.rcm2510361","url":null,"abstract":"<p><p>Abdominal aortic aneurysm (AAA) is a chronic vascular degenerative disease characterized by progressive segmental dilation of the abdominal aorta. The rupture of an AAA represents a leading cause of death in cardiovascular diseases. Despite numerous experimental and clinical studies examining potential drug targets and therapies, currently there are no pharmaceutical treatment to prevent AAA growth and rupture. Iron is an essential element in almost all living organisms and has important biological functions. Epidemiological studies have indicated that both iron deficiency and overload are associated with adverse clinical outcomes, particularly an increased risk of cardiovascular events. Recent evidence indicates that iron overload is involved in the pathogenesis of abdominal aortic aneurysms. In this review, we provide an overview of the role of iron overload in AAA progression and explore its potential pathological mechanisms. Although the exact molecular mechanisms of iron overload in the development of AAA remain to be elucidated, the inhibition of iron deposition may offer a promising strategy for preventing these aneurysms.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522754/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Kidney Function on Physiological Assessment of Coronary Circulation. 肾功能对冠状动脉循环生理评估的影响
IF 1.9 4区 医学
Reviews in cardiovascular medicine Pub Date : 2024-10-08 eCollection Date: 2024-10-01 DOI: 10.31083/j.rcm2510358
Wojciech Zasada, Barbara Zdzierak, Tomasz Rakowski, Beata Bobrowska, Agata Krawczyk-Ożóg, Sławomir Surowiec, Stanisław Bartuś, Andrzej Surdacki, Artur Dziewierz
{"title":"Impact of Kidney Function on Physiological Assessment of Coronary Circulation.","authors":"Wojciech Zasada, Barbara Zdzierak, Tomasz Rakowski, Beata Bobrowska, Agata Krawczyk-Ożóg, Sławomir Surowiec, Stanisław Bartuś, Andrzej Surdacki, Artur Dziewierz","doi":"10.31083/j.rcm2510358","DOIUrl":"10.31083/j.rcm2510358","url":null,"abstract":"<p><strong>Background: </strong>Diagnosing myocardial ischemia in chronic kidney disease (CKD) patients is crucial since coronary artery disease (CAD) forms the predominant cause of mortality in these patients. Thus, this study aimed to assess the impact of kidney function on the results of coronary circulation physiological assessment.</p><p><strong>Methods: </strong>Data were collected from 279 consecutive patients admitted to the Clinical Department of Cardiology and Cardiovascular Interventions at the University Hospital in Krakow. A total of 417 vessels were assessed for fractional flow reserve (FFR) and non-hyperemic resting pressure ratios, such as instantaneous wave-free ratio (iFR) and resting full-cycle ratio (RFR). Patients were categorized into two groups: glomerular filtration rate (GFR)-L (estimated GFR (eGFR) <70 mL/min/1.73 m<sup>2</sup>) and GFR-H (eGFR ≥70 mL/min/1.73 m<sup>2</sup>).</p><p><strong>Results: </strong>A total of 118 patients (42.3%) were included in the GFR-L group, while 161 patients (57.7%) were in the GFR-H group. The left anterior descending branch of the left coronary artery (LAD) was the assessed vessel in approximately 60% of procedures, the frequency of which was very similar in both study groups. Focusing solely on LAD assessments, both FFR metrics (continuous and binary) were comparable between the groups. In contrast, for non-LAD vessels, the GFR-H group revealed substantially reduced FFR values, with more vessels displaying significant constriction. Patients in the GFR-H group showed higher instances of FFR+ <math><mo>|</mo></math> iFR/RFR- discrepancies than their lower eGFR counterparts. An eGFR of 70 mL/min/1.73 m<sup>2</sup> was the optimal cut-off to differentiate patients concerning the mentioned discrepancies.</p><p><strong>Conclusions: </strong>Kidney function influenced the coronary circulation physiological assessment results. Patients with reduced eGFR tended to have negative hyperemic assessments, especially in non-LAD vessels.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信